# A Bioequivalence Study of CT-L02 Compared to Co-administration (CTL0201 and CTL0202) in Healthy Volunteers

> **NCT07128654** · PHASE1 · COMPLETED · sponsor: **Celltrion** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** CTL02
- **DRUG:** CTL0201
- **DRUG:** CTL0202

## Key facts

- **NCT ID:** NCT07128654
- **Lead sponsor:** Celltrion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-17
- **Primary completion:** 2025-10-05
- **Final completion:** 2025-10-26
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07128654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07128654, "A Bioequivalence Study of CT-L02 Compared to Co-administration (CTL0201 and CTL0202) in Healthy Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07128654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*